In this episode, we’re joined by Claire Love, PwC’s global health industries advisory leader. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market.
Egg freezing has gained popularity as a fertility preservation tool, but experts say high costs, uncertain outcomes and timing challenges continue to deter many women from pursuing it.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
They shared new developments, their views on AI, and what they're doing to disrupt the status quo in healthcare.
Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades.
Navigating fertility treatment is stressful. Many patients face hurdles when accessing fertility drugs, but here you will find the best pharmacies for affordable fertility drug delivery in the U.S.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
The women’s health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women’s health.
Cofertility raised $7.25 million in Series A funds, taking its total funding to date to $16 million. The startup is making egg freezing more accessible by tying it to egg donation — it offers one program in which women can pay to freeze their eggs and store them all for their own later use, and another one that allows women to freeze their eggs for free when they give half to a family who can’t otherwise conceive.
Through Evvy's vaginal microbiome test, consumers can now receive insights on fertility. The vaginal microbiome is often overlooked when it comes to fertility, according to Priyanka Jain, CEO and co-founder of Evvy.
President Donald Trump recently announced an executive order on IVF. But it doesn't actually do much yet. Rather, it's asking for a list of recommendations to protect IVF access.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Future Family launched a nationwide IVF insurance product on Wednesday. If families don't achieve a live birth after two cycles of IVF, they can get their money back.
Carrot Fertility has partnered with Priority Health to offer two design solutions for fully-funded and self-funded employer groups. These solutions include support for fertility treatment, pregnancy, postpartum care, gestational surrogacy, adoption, menopause and low testosterone.
Aetna will begin covering intrauterine insemination. It is the first major insurer to update this coverage policy nationwide, the payer claimed.
Gameto's $33 million Series B funding round was led by Two Sigma Ventures and RA Capital. The funding will help with the clinical development of its in vitro maturation product called Fertilo.
Providers have an ethical imperative to facilitate a truly informed choice for parents and donors, which means educating them about the facts around anonymous donation, the potential needs of their donor-conceived child, and the importance of choosing programs that dedicate time and effort toward obtaining updated medical information.